Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Available from: http://goldcopd.org/. Accessed May 20, 2019.
   Google Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC
   PubMed Web of Science ®Google Scholar
• Brown JP, Martinez CH. Chronic obstructive pulmonary disease comorbidities. Curr Opin Pulm Med. 2016;22(2):113–118. doi:10.1097/MCP.0000000000000241
   PubMed Web of Science ®Google Scholar
• Tsai TY, Livneh H, Lu MC, Tsai PY, Chen PC, Sung FC. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health. 2013;13:976. doi:10.1186/1471-2458-13-976
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Kaplan A, Hanania NA. COPD in primary care: key considerations for optimized management: anxiety and depression in chronic obstructive pulmonary disease: recognition and management. J Fam Pract. 2018;67(2 Suppl):S11–S18.
   PubMed Web of Science ®Google Scholar
• Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217–223. doi:10.1016/j.genhosppsych.2011.03.009
   PubMed Web of Science ®Google Scholar
• Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–777. doi:10.1378/chest.12-1911
   PubMed Web of Science ®Google Scholar
• Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD, Nett Research G. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105–116. doi:10.1080/15412550801941190
   PubMedGoogle Scholar
• Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293–299. doi:10.3109/15412555.2011.586659
   PubMedGoogle Scholar
• Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4):43S–56S. doi:10.1378/chest.08-0342
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Dryden S, Hanania NA. The responsiveness of the anxiety inventory for respiratory disease scale following pulmonary rehabilitation. Chest. 2016;150(1):188–195. doi:10.1016/j.chest.2016.02.658
   PubMed Web of Science ®Google Scholar
• Frei A, Muggensturm P, Putcha N, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67(8):904–911. doi:10.1016/j.jclinepi.2014.03.005
   PubMed Web of Science ®Google Scholar
• Phan T, Carter O, Waterer G, et al. Determinants for concomitant anxiety and depression in people living with chronic obstructive pulmonary disease. J Psychosom Res. 2019;120:60–65. doi:10.1016/j.jpsychores.2019.03.004
   PubMed Web of Science ®Google Scholar
• Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009;38(1):34–47. doi:10.1016/j.hrtlng.2008.02.005
   PubMed Web of Science ®Google Scholar
• Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47(4):312–319. doi:10.1176/appi.psy.47.4.312
   PubMed Web of Science ®Google Scholar
• Sunovion Pharmaceuticals Inc. Lonhala Magnair (glycopyrrolate) inhalation solution: highlights of prescribing information. 2017.
   Google Scholar
• Kerwin E, Donohue JF, Goodin T, Tosiello R, Wheeler A, Ferguson GT. Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials. Respir Med. 2017;132:238–250. doi:10.1016/j.rmed.2017.07.011
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey 1988–1994, NHANES III Raw Spirometry Data File (Series 11, No. 9A). Hyattsville, MD: Centers for Disease Control and Prevention; 2001.
   Google Scholar
• Miller MR. ATS/ERS task force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Jones PW. St. George’s respiratory questionnaire: MCID. COPD. 2005;2(1):75–79. doi:10.1081/copd-200050513
   PubMedGoogle Scholar
• Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774. doi:10.1016/j.rmed.2006.01.026
   PubMed Web of Science ®Google Scholar
• Vogele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med. 2008;102(5):764–773. doi:10.1016/j.rmed.2007.12.006
   PubMed Web of Science ®Google Scholar
• Rutherford BR, Roose SP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry. 2013;170(7):723–733. doi:10.1176/appi.ajp.2012.12040474
   PubMed Web of Science ®Google Scholar
• Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014;222(3):128–134. doi:10.1027/2151-2604/a000176
   PubMed Web of Science ®Google Scholar
• Hanania NA, Mullerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604–611. doi:10.1164/rccm.201003-0472OC
   PubMed Web of Science ®Google Scholar
• World Health Organization. Depression and other common mental disorders: global health estimates. Available from: https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf. Accessed June 06, 2019.
   Google Scholar
• Ohar J, Tosiello R, Goodin T, Sanjar S. Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. Int J COPD. 2019;14:27–37. doi:10.2147/COPD.S184808
   Google Scholar
• Ohar J, Ozol-Godfrey A, Goodin T, Sanjar S. Effect of gender on lung function and patient-reported outcomes in patients with COPD receiving nebulized glycopyrrolate. Int J COPD. 2020;15:995–1004. doi:10.2147/COPD.S24030
   Google Scholar
• Kerwin EM, Tosiello R, Price B, Sanjar S, Gooding T. Effect of background long-acting beta 2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD. Int J COPD. 2018;13:2917–2929. doi:10.2147/COPD.S172408
   Google Scholar
• Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction. 2006;101(12):1814–1821. doi:10.1111/j.1360-0443.2006.01616.x
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Goodin T, Bowling A, et al. Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies. Respir Res. 2019;20:135. doi:10.1186/s12931-019-1112-0
   PubMed Web of Science ®Google Scholar
• Labor S, Labor M, Juric I, Vuksic Z. The prevalence and pulmonary consequences of anxiety and depressive disorders in patients with asthma. Coll Antropol. 2012;36(2):473–481.
   PubMedGoogle Scholar
• Goodwin RD, Chuang S, Simuro N, Davies M, Pine DS. Association between lung function and mental health problems among adults in the United States: findings from the First National Health and Nutrition Examination Survey. Am J Epidemiol. 2007;165(4):383–388. doi:10.1093/aje/kwk026
   PubMed Web of Science ®Google Scholar
• Momtaz OM, Rabei SM, Tawfike NR, Hasan AA. Effect of treatment of depression and anxiety on physiological state of severe COPD patients. Egypt J Chest Dis Tuberc. 2015;64(1):29–34. doi:10.1016/j.ejcdt.2014.08.006
   Google Scholar
• Chetta A, Foresi A, Marangio E, Olivieri D. Psychological implications of respiratory health and disease. Respiration. 2005;72(2):210–215. doi:10.1159/000084056
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–2107. doi:10.1001/archinte.160.14.2101
   PubMed Web of Science ®Google Scholar
• Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346–2350. doi:10.1183/09031936.96.09112346
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31(7):483–492. doi:10.1007/s40266-014-0186-0
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Mullerova H, Hanania NA, et al. Long-term course of depression trajectories in patients with COPD: a 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. Chest. 2016;149(4):916–926. doi:10.1016/j.chest.2015.10.081
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001;16(5):451–454. doi:10.1002/gps.461
   PubMed Web of Science ®Google Scholar